{
  "zip": "80401",
  "sector": "Healthcare",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "Theralink Technologies, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapy products. The company has proprietary rights to immunotherapy platform focusing on prostate and breast cancers. The company's lead product is ProscaVax, which is in phase 2 clinical trials for the treatment of prostate cancer. It is also developing targeted therapies. Theralink Technologies, Inc. has a partnership with Perthera, Inc. to facilitate and enhance access to Theralink's 32 phosphoprotein panel, the Theralink assay, for breast cancer patients. The company was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies, Inc. is based in Baton Rouge, Louisiana.",
  "city": "Golden",
  "phone": "888 585 4923",
  "state": "CO",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.theralink.com",
  "maxAge": 1,
  "address1": "15000 West 6th Avenue",
  "industry": "Biotechnology",
  "address2": "Suite 400",
  "previousClose": 0.1971,
  "regularMarketOpen": 0.135,
  "twoHundredDayAverage": 0.26740694,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.2289,
  "navPrice": null,
  "averageDailyVolume10Day": 3424,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.1971,
  "fiftyDayAverage": 0.15043788,
  "trailingAnnualDividendRate": null,
  "open": 0.135,
  "averageVolume10days": 3424,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.278361,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.135,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1449,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 320018,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3193,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.135,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1449,
  "fiftyTwoWeekHigh": 1.25,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.06,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.2289,
  "exchange": "PNK",
  "shortName": "ONCBIOMUNE PHARMACEUTICALS INC",
  "longName": "Theralink Technologies, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "OBMP",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_304861406",
  "uuid": "7bc10ae3-28f7-3a2f-a474-c25b72ce637d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -2.814,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 1398070,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -22.682,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -10027338,
  "trailingEps": -16.126,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.4186,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1585612800,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 853578,
  "enterpriseValue": 4298374,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1440720000,
  "lastSplitFactor": "7:1000",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.135,
  "logo_url": "https://logo.clearbit.com/theralink.com"
}